GUIDE-US: Grade-Informed Unpaired Distillation of Encoder Knowledge from Histopathology to Micro-UltraSound
Emma Willis, Tarek Elghareb, Paul F. R. Wilson, Minh Nguyen Nhat To, Mohammad Mahdi Abootorabi, Amoon Jamzad, Brian Wodlinger, Parvin Mousavi, Purang Abolmaesumi
TL;DR
GUIDE-US introduces an unpaired histopathology-guided knowledge distillation framework to train a micro-US encoder for prostate cancer grading. The method uses a two-stage teacher-student setup: a histopathology foundation-model teacher trained on whole-slide images guides a micro-US student via ABMIL-based aggregation and a triplet distillation objective, with a weakly supervised segmentation branch. Results show improved detection of clinically significant prostate cancer at 60% specificity and better ISUP-grade discrimination compared to state-of-the-art imaging baselines, with statistically significant gains. This approach enables earlier, more reliable risk stratification using imaging alone, potentially improving biopsy targeting and clinical decision-making, with code to be released upon publication.
Abstract
Purpose: Non-invasive grading of prostate cancer (PCa) from micro-ultrasound (micro-US) could expedite triage and guide biopsies toward the most aggressive regions, yet current models struggle to infer tissue micro-structure at coarse imaging resolutions. Methods: We introduce an unpaired histopathology knowledge-distillation strategy that trains a micro-US encoder to emulate the embedding distribution of a pretrained histopathology foundation model, conditioned on International Society of Urological Pathology (ISUP) grades. Training requires no patient-level pairing or image registration, and histopathology inputs are not used at inference. Results: Compared to the current state of the art, our approach increases sensitivity to clinically significant PCa (csPCa) at 60% specificity by 3.5% and improves overall sensitivity at 60% specificity by 1.2%. Conclusion: By enabling earlier and more dependable cancer risk stratification solely from imaging, our method advances clinical feasibility. Source code will be publicly released upon publication.
